Markus Matilainen

10PUBLICATIONS

50CO-AUTHORS

Peripheral nervous systemNeurology and neuromuscular diseasesInnate immunityRegenerative medicine (incl. stem cells)Medical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 31, 2026

TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis.

|Jul 03, 2025

Synaptic Density in Multiple Sclerosis: An In Vivo Study Using [<sup>11</sup>C]UCB-J-PET Imaging.

Amelie Luoma, Markus Matilainen, Jouni Mikael Tuisku

|May 16, 2025

Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis.

Venla Ahola, Maija Saraste, Marjo Nylund

|Apr 29, 2025

Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis.

Luisa Klotz, Joost Smolders, Jussi Lehto

|Jun 22, 2023

TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis.

Eero Polvinen, Markus Matilainen, Marjo Nylund

|Oct 17, 2022

A review of second-order blind identification methods.

Yan Pan, Markus Matilainen, Sara Taskinen

Pageof 2

Frequent Collaborators

Laura M Airas

Marjo Nylund

Maija Saraste

Jussi Lehto

Amelie Luoma

Richard Aarnio

Anniina Snellman

Juha O Rinne

Jouni Tuisku

Johan Rajander

Frequent Collaborators

Laura M Airas

Marjo Nylund

Maija Saraste

Jussi Lehto